{"id":"https://openalex.org/W4408823524","doi":"https://doi.org/10.1177/10760296251327592","title":"Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban","display_name":"Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban","publication_year":2025,"publication_date":"2025-03-25","ids":{"openalex":"https://openalex.org/W4408823524","doi":"https://doi.org/10.1177/10760296251327592","pmid":"https://pubmed.ncbi.nlm.nih.gov/40129292"},"language":"en","primary_location":{"id":"doi:10.1177/10760296251327592","doi":"https://doi.org/10.1177/10760296251327592","is_oa":true,"landing_page_url":"https://doi.org/10.1177/10760296251327592","pdf_url":null,"source":{"id":"https://openalex.org/S8942861","display_name":"Clinical and Applied Thrombosis/Hemostasis","issn_l":"1076-0296","issn":["1076-0296","1938-2723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Applied Thrombosis/Hemostasis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1177/10760296251327592","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076322910","display_name":"Veronica Ashton","orcid":"https://orcid.org/0000-0003-4880-1897","observed_orcids":["https://orcid.org/0000-0003-4880-1897"]},"institutions":[{"id":"https://openalex.org/I4391767992","display_name":"Janssen Scientific Affairs (United States)","ror":"https://ror.org/04w4xsz15","country_code":null,"type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4391767992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Veronica Ashton","raw_affiliation_strings":["Janssen Scientific Affairs, LLC","Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Titusville, NJ, USA"],"raw_orcid":"https://orcid.org/0000-0003-4880-1897","affiliations":[{"raw_affiliation_string":"Janssen Scientific Affairs, LLC","institution_ids":["https://openalex.org/I4391767992"]},{"raw_affiliation_string":"Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Titusville, NJ, USA","institution_ids":["https://openalex.org/I4391767992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061998147","display_name":"Guillaume Germain","orcid":"https://orcid.org/0000-0002-4525-7673","observed_orcids":["https://orcid.org/0000-0002-4525-7673"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Guillaume Germain","raw_affiliation_strings":["Groupe d\u2019Analyse, Lt\u00e9e, Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe d\u2019Analyse, Lt\u00e9e, Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044321016","display_name":"Julien Boudreau","orcid":"https://orcid.org/0009-0008-1316-9645","observed_orcids":["https://orcid.org/0009-0008-1316-9645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julien Boudreau","raw_affiliation_strings":["Groupe d\u2019Analyse, Lt\u00e9e, Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe d\u2019Analyse, Lt\u00e9e, Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064136522","display_name":"Manasvi Sundar","orcid":"https://orcid.org/0000-0001-5858-8685","observed_orcids":["https://orcid.org/0000-0001-5858-8685"]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manasvi Sundar","raw_affiliation_strings":["Analysis Group, Inc., Los Angeles, CA, USA"],"raw_orcid":"https://orcid.org/0000-0001-5858-8685","affiliations":[{"raw_affiliation_string":"Analysis Group, Inc., Los Angeles, CA, USA","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039497950","display_name":"Sean D. MacKnight","orcid":"https://orcid.org/0000-0001-5032-2110","observed_orcids":["https://orcid.org/0000-0001-5032-2110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean D MacKnight","raw_affiliation_strings":["Groupe d\u2019Analyse, Lt\u00e9e, Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":"https://orcid.org/0000-0001-5032-2110","affiliations":[{"raw_affiliation_string":"Groupe d\u2019Analyse, Lt\u00e9e, Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087242254","display_name":"Shawn N. Murphy","orcid":"https://orcid.org/0000-0002-1905-8806","observed_orcids":["https://orcid.org/0000-0002-1905-8806"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shawn Murphy","raw_affiliation_strings":["Mass General Brigham, Somerville, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mass General Brigham, Somerville, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044957757","display_name":"Yichuan Grace Hsieh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yichuan G. Hsieh","raw_affiliation_strings":["Mass General Brigham, Somerville, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mass General Brigham, Somerville, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017834828","display_name":"Fran\u00e7ois Lalibert\u00e9","orcid":"https://orcid.org/0000-0003-2601-6214","observed_orcids":["https://orcid.org/0000-0003-2601-6214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Lalibert\u00e9","raw_affiliation_strings":["Groupe d\u2019Analyse, Lt\u00e9e, Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe d\u2019Analyse, Lt\u00e9e, Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5061998147"],"corresponding_institution_ids":[],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":{"value":2650,"currency":"USD","value_usd":2650},"fwci":1.8884,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.8281493,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"31","issue":null,"first_page":"10760296251327592","last_page":"10760296251327592"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pulmonary-embolism","display_name":"pulmonary embolism","score":0.7870000004768372},{"id":"https://openalex.org/keywords/hospital-readmission","display_name":"hospital readmission","score":0.8149999976158142},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.9950000047683716},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":1.0},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9729999899864197},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9190000295639038},{"id":"https://openalex.org/keywords/post-discharge-outcomes","display_name":"post-discharge outcomes","score":0.6669999957084656},{"id":"https://openalex.org/keywords/anticoagulant-comparison","display_name":"anticoagulant comparison","score":0.6010000109672546},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6890000104904175},{"id":"https://openalex.org/keywords/inverse-probability-of-treatment-weighting","display_name":"inverse probability of treatment weighting","score":0.7009999752044678},{"id":"https://openalex.org/keywords/risk-adjustment","display_name":"risk adjustment","score":0.3540000021457672},{"id":"https://openalex.org/keywords/duration-of-anticoagulation","display_name":"anticoagulation duration","score":0.4620000123977661},{"id":"https://openalex.org/keywords/anticoagulation-discontinuation","display_name":"anticoagulation discontinuation","score":0.44600000977516174},{"id":"https://openalex.org/keywords/anticoagulation-initiation","display_name":"anticoagulation initiation","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9372323751449585},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.9036611318588257},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.8867179155349731},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.767342209815979},{"id":"https://openalex.org/C2776265017","wikidata":"https://www.wikidata.org/wiki/Q220570","display_name":"Pulmonary embolism","level":2,"score":0.7019176483154297},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.625687837600708},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5694888830184937},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5689547657966614},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.4849431812763214},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.2240292727947235},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.16503381729125977}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010359","descriptor_name":"Patient Readmission","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D010359","descriptor_name":"Patient Readmission","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D010359","descriptor_name":"Patient Readmission","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D010359","descriptor_name":"Patient Readmission","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D010359","descriptor_name":"Patient Readmission","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011655","descriptor_name":"Pulmonary Embolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011655","descriptor_name":"Pulmonary Embolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011655","descriptor_name":"Pulmonary Embolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011655","descriptor_name":"Pulmonary Embolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011655","descriptor_name":"Pulmonary Embolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1177/10760296251327592","doi":"https://doi.org/10.1177/10760296251327592","is_oa":true,"landing_page_url":"https://doi.org/10.1177/10760296251327592","pdf_url":null,"source":{"id":"https://openalex.org/S8942861","display_name":"Clinical and Applied Thrombosis/Hemostasis","issn_l":"1076-0296","issn":["1076-0296","1938-2723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Applied Thrombosis/Hemostasis","raw_type":"journal-article"},{"id":"pmid:40129292","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40129292","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11938890","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11938890","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clin Appl Thromb Hemost","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:c865025a686047c8a6b9b9eac82d475a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c865025a686047c8a6b9b9eac82d475a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Applied Thrombosis/Hemostasis, Vol 31 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/10760296251327592","doi":"https://doi.org/10.1177/10760296251327592","is_oa":true,"landing_page_url":"https://doi.org/10.1177/10760296251327592","pdf_url":null,"source":{"id":"https://openalex.org/S8942861","display_name":"Clinical and Applied Thrombosis/Hemostasis","issn_l":"1076-0296","issn":["1076-0296","1938-2723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Applied Thrombosis/Hemostasis","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8299999833106995}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320317188","display_name":"Janssen Scientific Affairs","ror":"https://ror.org/04w4xsz15"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W28542632","https://openalex.org/W1964644585","https://openalex.org/W2016362027","https://openalex.org/W2023187859","https://openalex.org/W2061326496","https://openalex.org/W2071111754","https://openalex.org/W2079491969","https://openalex.org/W2265545986","https://openalex.org/W2289088467","https://openalex.org/W2538338339","https://openalex.org/W2569402644","https://openalex.org/W2575303210","https://openalex.org/W2588203024","https://openalex.org/W2606145829","https://openalex.org/W2731964881","https://openalex.org/W2795881734","https://openalex.org/W2799885026","https://openalex.org/W2810689777","https://openalex.org/W2895250534","https://openalex.org/W2914247996","https://openalex.org/W2946787119","https://openalex.org/W2959547670","https://openalex.org/W2968913818","https://openalex.org/W2971121646","https://openalex.org/W2996752572","https://openalex.org/W3033253379","https://openalex.org/W3090209681","https://openalex.org/W3109839148","https://openalex.org/W3124169281","https://openalex.org/W3170034452","https://openalex.org/W3174519219","https://openalex.org/W3193235957","https://openalex.org/W4210254800","https://openalex.org/W4210745803","https://openalex.org/W4221055333","https://openalex.org/W4283462656","https://openalex.org/W4297176423","https://openalex.org/W4383197900","https://openalex.org/W4391605535"],"related_works":["https://openalex.org/W4400816999","https://openalex.org/W2899376801","https://openalex.org/W3152617061","https://openalex.org/W1898315192","https://openalex.org/W2093259736","https://openalex.org/W4245137039","https://openalex.org/W4391812656","https://openalex.org/W2982257806","https://openalex.org/W2999951153","https://openalex.org/W4197684"],"abstract_inverted_index":{"Background":[0],"Although":[1],"hospital":[2,32,92,176,196,243],"readmission":[3,19,33,177,197,244],"after":[4],"pulmonary":[5],"embolism":[6],"(PE)":[7],"is":[8,11],"common,":[9],"there":[10],"limited":[12],"evidence":[13],"on":[14,64],"the":[15,27,80,85],"comparative":[16],"risk":[17,29,173,240],"of":[18,30,129,174,195,241],"between":[20,109],"rivaroxaban":[21,40,65,143],"and":[22,97,106,119,153,217],"apixaban.":[23,42,253],"This":[24,44],"study":[25,46],"compared":[26,108],"real-world":[28],"all-cause":[31,175,242],"among":[34],"patients":[35,61],"with":[36,39,76,169,237],"PE":[37,87],"treated":[38],"or":[41,66],"Methods":[43],"retrospective":[45],"used":[47,133],"data":[48],"from":[49,121,249],"Mass":[50],"General":[51],"Brigham's":[52],"Research":[53],"Patient":[54],"Data":[55],"Registry":[56],"(01/2013-05/2023)":[57],"to":[58,84,134],"identify":[59],"adult":[60],"newly":[62],"initiated":[63],"apixaban":[67,155],"during":[68],"a":[69,170],"PE-related":[70,250],"hospitalization":[71,88,251],"(discharge":[72],"=":[73,192,215,231],"index).":[74],"Patients":[75],"venous":[77],"thromboembolism":[78],"in":[79],"3":[81],"months":[82],"prior":[83],"index":[86],"were":[89,101,107,164],"excluded.":[90],"All-cause":[91],"readmissions":[93],"at":[94,178,202],"30,":[95],"60,":[96],"90":[98,218,246],"days":[99,180,204,219,247],"post-index":[100,181,220],"assessed":[102],"using":[103,111],"Kaplan-Meier":[104],"analysis":[105],"cohorts":[110],"hazard":[112],"ratios":[113],"(HRs),":[114],"95%":[115],"confidence":[116],"intervals":[117],"(CIs),":[118],"p-values":[120],"Cox":[122],"proportional":[123],"hazards":[124],"regression":[125],"models.":[126],"Inverse":[127],"probability":[128],"treatment":[130],"weighting":[131],"was":[132,167,198,235],"adjust":[135],"for":[136],"baseline":[137],"confounding.":[138],"Results":[139],"In":[140],"total,":[141],"686":[142],"(mean":[144,156],"age:":[145,157],"59.5;":[146],"female:":[147,159],"50.1;":[148],"Quan-Charlson":[149],"comorbidity":[150],"index:":[151],"1.51)":[152],"2207":[154],"60.6;":[158],"50.8;":[160],"Quan-CCI:":[161],"1.58)":[162],"initiators":[163],"included.":[165],"Rivaroxaban":[166,234],"associated":[168,236],"26%":[171],"lower":[172,201,239],"30":[179],"(12.3%":[182],"vs":[183,206,222],"16.5%;":[184],"HR":[185,208,224],"[95%":[186,209,225],"CI]:":[187,210,226],"0.74":[188,211],"[0.58,":[189],"0.94];":[190],"P":[191,214,230],".012).":[193],"Risk":[194],"also":[199],"significantly":[200,238],"60":[203],"(17.0%":[205],"22.3%;":[207],"[0.61,":[212],"0.91];":[213],".004)":[216],"(21.6%":[221],"25.6%;":[223],"0.81":[227],"[0.68,":[228],"0.98];":[229],".029).":[232],"Conclusions":[233],"within":[245],"post-discharge":[248],"than":[252]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-10-15T10:00:46.086208","created_date":"2025-10-10T00:00:00"}